Introduction
Should Clozapine Be a First-Line Treatment for Schizophrenia? The Rationale for a Double-Blind Clinical Trial in First-Episode Patients
Time Required for Initial Improvement During Clozapine Treatment of Refractory Schizophrenia
Effects of Clozapine on Smoking in Chronic Schizophrenic Outpatients
Clozapine Increases EEG Photic Driving in Clinical Responders
Clozapine Eligibility Among State Hospital Patients
Risperidone in the Treatment of Patients With Chronic Schizophrenia: A Multi-National, Multi-Centre, Double-Blind, Parallel-Group Study Versus Haloperidol
ICI 204,636, an Atypical Antipyschotic: Efficacy and Safety in a Multicenter, Placebo-Controlled Trial in Patients With Schizophrenia
Idazoxan and Response to Typical Neuroleptics in Treatment-Resistant Schizophrenia: Comparison With the Atypical Neuroleptic, Clozapine
Convulsive Therapy in Schizophrenia?
Dose-Finding Trial of D-Cycloserine Added to Neuroleptics for Negative Symptoms in Schizophrenia
High-Resolution SPECT Study of Regional Cerebral Blood Flow in Drug-Free and Drug-Naive Schizophrenic Patients
Tardive Dyskinesia in Schizophrenia: Relationship to Minor Physical Anomalies, Frontal Lobe Dysfunction and Cerebral Structure on Magnetic Resonance Imaging
Risk of Tardive Dyskinesia in Older Patients: A Prospective Longitudinal Study of 266 Outpatients
A Double-blind Placebo-Controlled Study of Vitamin E Treatment of Tardive Dyskinesia
Hospital Use of Antipsychotic Agents in 1989 and 1993: Stable Dosing With Decreased Length of Stay
The Epidemiology of Drug-Induced Akathisia: Part I. Acute Akathisia
The Epidemiology of Drug-Induced Akathisia: Part II. Chronic, Tardive, and Withdrawal Akathisias
The Camden Schizophrenia Surveys: I. The Psychiatric, Behavioural and Social Characteristics of the Severely Mentally III in an Inner London Health District
The Camden Schizophrenia Surveys: II. High Prevalence of Schizophrenia in an Inner London Borough and Its Relationship to Socio-demographic Factors
Newer Antidepressants and the Cytochrome P450 System
Nonresponse to Reinstituted Lithium Prophylaxis in Previously Responsive Bipolar Patients: Prevalence and Predictors
Addition of Monoamine Oxidase Inhibitors to Carbamazepine: Preliminary Evidence of Safety and Antidepressant Efficacy in Treatment-Resistant Depression
A Pharmacoeconomic Model of Divalproex vs. Lithium in the Acute and Prophylactic Treatment of Bipolar I Disorder
Renal Function on and off Lithium in Patients Treated With Lithium for 15 Years or More: A Controlled, Prospective Lithium-Withdrawal Study
Effects of Third Trimester Fluoxetine Exposure on the Newborn
Double-blind, Placebo-controlled Trial of Methylphenidate in Older, Depressed, Medically III Patients
Antidepressant-induced Mania and Cycle Acceleration: A Controversy Revisited
Variation in ECT Use in the United States
Trends in Pharmacotherpy of Schizoaffective and Bipolar Affective Disorders: A 5-Year Naturalistic Study
Antidepressant Therapy: A Possible Cause of Atypical Cutaneous Lymphoid Hyperplasia
Meta-analysis of Randomized Controlled Trials of Cranial Electrostimulation: Efficacy in Treating Selected Psychological and Physiological Conditions
Double-blind, Placebo-controlled, Crossover Trial of Inositol Treatment for Panic Disorder
Prolonged Sedation Due to Accumulation of Conjugated Metabolites of Midazolam
Predictors of Alprazolam Discontinuation With and Without Cognitive Behavior Therapy in Panic Disorder
Clinical Aspects of Chronic Use of Alprazolam and Lorazepam
Lack of Efficacy of Clozapine Monotherapy in Refractory Obsessive-Compulsive Disorder
Fluvoxamine Versus Clomipramine for Obsessive-Compulsive Disorder: A Double-blind Comparison
Sertraline for Social Phobia: A Double-blind, Placebo-controlled Crossover Study
Is Methylphenidate Like Cocaine? Studies on Their Pharmacokinetics and Distribution in the Human Brain
Liability to Alprazolam Abuse in Daughters of Alcoholics
Topiramate Placebo-Controlled Dose-Ranging Trial in Refractory Partial Epilepsy Using 600-, 800-, and 1,000-mg Daily Dosages
Pharmacologic Management of Psychiatric Illness During Pregnancy: Dilemmas and Guidelines
Limited Usefulness of Electroconvulsive Therapy in Progressive Supranuclear Palsy
The Effects of Amantadine and Pemoline on Cognitive Functioning in Multiple Sclerosis
A Double-blind Study of Subcutaneous Dihydroergotamine vs Subcutaneous Sumatriptan in the Treatment of Acute Migraine
Pharmacotherapy of Adult Attention Deficit/Hyperactivity Disorder: A Review
LSD-like Panic From Risperidone in Post-LSD Visual Disorder
A Long-term, Double-blind, Placebo-controlled Crossover Trial of the Efficacy of Fluoxetine for Trichotillomania